Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 4:24 PM

Kelly Martin

Type: Person
Name: Kelly Martin
First Reported 11/18/2009 - Updated 11/18/2009 - 2 Documents (in Corporate Deals)
Elan and partner Biogen Idec aim to find a 'balanced way' of alerting investors about the number of brain infections linked to their Tysabri multiple sclerosis drug by the end of this year after a surge in cases, CEO Kelly Martin said yesterday. It was ... [Irish Independent - 11/18/2009]
First Reported 10/22/2009 - Updated 10/22/2009 - 1 Documents (in Biology)
Johnson & Johnson - Click to view image in its original context
Johnson & Johnson
Kelly Martin, chief executive of Elan, said the Irish drugs group would focus on increasing sales of its multiple sclerosis drug Tysabri, following the sale of a stake... ... [FT.com - Health - 10/22/2009]
First Reported 10/23/2009 - Updated 10/23/2009 - 1 Documents (in Politics)
Halifax, N.S. – The Volunteer Host Program at Halifax Stanfield International Airport (HSIA) celebrates its ninth anniversary this month.The “Tartan Team” – so called because of their distinctive tartan vests – has logged over 140,000 hours of service ... [International Airport Review - 10/23/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents
Endemol NV - Click to view 360-page
Endemol NV
LONDON: has sold an additional two seasons of the hit Australian drama series Home and Away to New Zealand's TV3.The show, produced by Seven Network in Australia, centers on the community of the fictitious beachside town of Summer Bay. The residents are ... [World Screen News - 11/03/2009]
First Reported 07/07/2009 - Updated 07/07/2009 - 1 Documents (in Health)
Elan(ELN Quote) CEO Kelly Martin deserves praise for shepherding last week's deal with Johnson & Johnson(JNJ Quote) that puts the Irish drugmaker on firmer financial footing.Given that I awarded Martin the ignominious honor of being the last December, ... [TheStreet.com - 07/07/2009]
First Reported 07/21/2009 - Updated 07/21/2009 - 1 Documents
Elan Corporation, plc - Click to view image in its original context
Elan Corporation, plc
ELA - Elan Corporation Latest Prices Name Price % Elan Corporation 5.64 +0.09% techMARK 1,296 +0.98% LONDON (SHARECAST) - Neuroscience-based biotechnology company Elan remained mired in the red in the second quarter despite a strong performance from ... [ShareCast - 07/21/2009]
First Reported 10/21/2009 - Updated 10/21/2009 - 1 Documents (in Market News)
Athlone-based pharmaceutical group Elan has today reported net income of $52.3 million for its fiscal third quarter compared to a loss of $83.5 million last year.For the third quarter of 2009, Elan reported adjusted earnings before interest, tax, depreciation ... [Irish Times - 10/21/2009]

Quotes

Cathy Payne, the CEO at , commented: "home and away remains one of the longest running and most successful dramas in our portfolio. its as addictive today as it ever has been and continues to be followed by generations of loyal fans all over the world. were extremely proud of the show and delighted to be partnering with tv3 for a further two seasons." Kelly Martin, the director of programming at TV3 Network Services, said: Home and Away is one of TV3s most important shows, and were thrilled to have...
The third quarter of 2009 proved to be a time of "significant transformation for Elan," said Kelly Martin, chief executive of Elan. "completion of the transaction and the subsequent refinancing of our balance sheet provide strategic flexibility and financial stability for the company."
Revenue from the Biopharmaceuticals business grew by 16% while revenue from the Elan Drug Technologies (EDT) business increased by 10%. "during the first six months of 2009, we grew revenues, added an additional approach to alzheimer s disease and successfully completed our strategic review with the announcement of a transformative transaction with johnson & johnson" said Elan's chief executive officer, Kelly Martin

More Content

All (19) | News (18) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (1)
sort by: Date | Relevance
Business in brief: MS wonder drug 'balanced alert' [Irish Independent - 11/18/2009]
MS wonder drug 'balanced alert' [Irish Independent - 11/18/2009]
Home and Away Picked Up for Two More Seasons in NZ [World Screen News - 11/03/2009]
Airport Volunteer Host Program Celebrates Ninth... [International Airport Review - 10/23/2009]
Sales of Tysabri fuel growth in Elan profits [Irish Times - 10/22/2009]
Third-quarter profit gives Elan shares a 4.5pc ... [Irish Independent - 10/22/2009]
Elan focuses on boosting MS drug sales after se... [FT.com - Health - 10/22/2009]
Elan pins hopes on multiple sclerosis drug [Cafepharma - 10/21/2009]
Elan posts Q3 net profit of $52.3m [Spectator - 10/21/2009]
Tysabri sales lift Elan revenues [Irish Times - 10/21/2009]
Elan Corporation PLC UK Regulatory Announcement... [Business Wire UK - 10/21/2009]
Elan Reports Third Quarter 2009 Financial Results [Stockwatch - 10/21/2009]
Losses narrow at Elan [ShareCast - 07/21/2009]
Elan Does Right by Its Shareholders [TheStreet.com - 07/07/2009]
J&J to acquire Alzheimer's Immunotherapy Pr... [PharmaBiz - 07/04/2009]
New kids’ books to enjoy this summe..... [News and Sentinel - 06/28/2009]
STAR STUDENTS HONORABLE MENTIONMEDIN... [Akron Beacon Journal - 05/25/2009]
Elan cuts 230 jobs, reiterates 2009 guidance [ShareCast - 02/25/2009]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Network
Trends

  •  
  •  
  •